Amalgamated Bank’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,487
Closed -$90K 2997
2022
Q3
$90K Hold
4,487
﹤0.01% 2200
2022
Q2
$31K Buy
4,487
+380
+9% +$2.67K ﹤0.01% 2712
2022
Q1
$38K Buy
+4,107
New +$43.7K ﹤0.01% 2598

Amalgamated Bank's FMTX Position: Q4 2022 in Review

Amalgamated Bank sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 4,487 shares — an estimated $90K sold.

Amalgamated Bank first reported a position in FMTX in Q1 2022 and held it in 3 quarters. The position peaked at $90K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Amalgamated Bank reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Amalgamated Bank sold 4,487 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $90K.
  • Amalgamated Bank first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Amalgamated Bank's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $90K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Amalgamated Bank's 13F filing for Q4 2022, filed 10 Feb 2023.